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Epidemiological studiessuggestanassociation betweenexposuretodieselemnissionsandanincreasedincidenceoflung
and bladder cancer in humans. Ofthecompoundsassociated with dieselemissions, 1,dinitropyreneisa particularly
potent mutagenandcarcinogen. Intheseexperiments wea[WIiniered [4 H9,1H1 6-dinitropyrene (30or100Nodirecty
tothelungsofF344 ratsaccording to a protocol known toinducelungtumorsandcharacterizedthe DNAadducts pre-
sent inthetargettissue. Inaddition, weexamined theadductspresentinspleenlymphocytesandassayedfortheinduc-
tionofmutations atthehypo anth ine phosphoribosyltransferase lcus inthesecells, asmeasredbythefrequency
of6-thioguanine-resistant (TGr)T-lymph Adductformationwasdetected inbothlungandspleenlymphocyteDNA,
with theextentofbindingbeing dose-dependentinthelymphocytesbutnotthelung 32P_postiabelinganalysesindicated
the formation ofamajor DNAadduct, N-(deoxyguanosin48-yl)-i-amino-6nitropyrene, inboth tissues. 1,fDinitropyrene
treatment resulted in a dose-dependent increase inTGF T-lymphocytes, withthe increasebeing detected forat least21
weeksaftertreatment. Thesedataindicatethatlfdinitropyreneismetaboicallyactivatedbynitroreduction toformDNA
adductsinboththetargettissueandspleenlymphocytesandthatatumorigenicdoseresultsinasignificantinductionof
TGrT-lymphocytes.
Introduction
Nitropolycyclic aromatic hydrocarbons (nitro PAHs) arewide-
spread environmental contaminants resulting from a numberof
combustion processes (1). A particularly notable source ofthese
compounds isdiesel exhaust, which induces lungtumors in ex-
perimental animals and has been associated with the induction
of lung and urinary bladder cancer in humans (2). Although
more than 50 nitro PAHs have been detected in diesel engine
emissions, muchemphasis hasbeenplaced onthenitropyrenes.
I-Nitropyrene, which is the predominant nitropyrene found in
diesel particleextracts, ismutagenic inbacterial andmammalian
cells andtumorigenic in rats and mice(2,3). Dinitropyrenes are
detected at much lower concentrations than 1-nitropyrene;
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however, these compounds, in particular 1,6- and 1,8-
dinitropyrene, are exceedingly potentbacterial mutagens and,
when tested in the same animal model, are much more
tumorigenicthan 1-nitropyrene(3). Thesefindingssuggestthat
dinitropyrenes maybeimportantmarkersforassessingtherisk
associated with exposureto diesel emissions.
The metabolic activation of dinitropyrenes involves nitro-
reduction to N-hydroxyamino intermediates followed by 0-
acetylation to give N-acetoxy derivatives that will react with
DNA (3). DNA adducts resulting from the nitroreduction and
O-acetylation of 1,6- and 1,8-dinitropyrene have been charact-
erizedanddetectedinbacteriaandexperimentalanimals. These
adducts are presumably responsible for the mutagenic and
tumorigenic responses observed withthedinitropyrenes.
Although DNA adducts are important biomarkers for car-
cinogenexposure, theyhaveafinitelifetimeduetoDNArepair
and/or cell turnover. Thus, additional techniques allowing
assessment of more-than-recent exposures should clearly be
useful. One such approach has been to assay forantibodies to
DNAadductsinworkersexposedtohighlevelsofPAHs(4). AnSMITHETAL.
alternative technique is todetermine ifcarcinogenexposurein-
duces lymphocyte mutations because, ifmutationsoccurinstem
cell populations, they may bedetected forperiodslongafterthe
carcinogen exposure (5). Additional advantagesofthelatterap-
proach arethat itprovides abiological assessmentoftheimpact
ofparticular DNA adducts andthatthetypesofmutations may
becompoundspecific, making itpossibletoobtainafingerprint
ofDNA sequence changes caused by carcinogen exposures.
In these experiments, we administered 1,6-dinitropyrene
directly to the lungs of F344 rats according to a protocol (6)
known to induce lungtumorsandcharacterizedtheDNAadducts
present inthetargettissue. Inaddition, weexaminedtheadducts
present in spleen lymphocytes and assayed forthe induction of
mutations at the hypoxanthine-guanine phosphoribosyltrans-
ferase (hprt) locus in these cells.
Materials and Methods
DNA Adduct Analyses
MaleF344rats(12weeksold;obtainedfromthebreedingcolo-
nyattheNationalCenterforToxicological Research,Jefferson,
AR) wereanesthetizedwithamixtureofketamineand xylazine
(7) and subjected to a left lateral thoracotomy. [4,5,9,10-3H]
1,6-Dinitropyrene (0, 30, or 100,Ag; 767or 1059mCi/mmole) in
50ALofbeeswax andtricaprylin (1:1) wasthenadministered us-
ing the lung implantation method of Stanton et al. (8) as de-
scribedbyIwagawaandco-workers(6). Three, 7, 14, and28days
aftertreatment, twoorthreeanimals wereexposedtocarbondi-
oxide, decapitated, and the lungs andspleens werequickly ex-
cised. Lungnuclei werepreparedbythemethodofBasleretal.
(9), and spleen lymphocytes were isolated by thetechnique of
Aidoo etal. (10). DNA wasextractedfrom the nuclei andcells
by slight modifications ofthe method reported inBeland et al.
(11). The DNA wasquantified by UVspectrometry, andtheex-
tent ofadduct formation was determined by liquid scintillation
counting.
Tocharacterize theadducts presentin lung nuclei andspleen
lymphocytes, additional aliquotsofDNA wereanalyzedby32p-
postlabeling, which was conducted asdescribed inSmith etal.
(12).
Analysis ofMutation Induction at the hprtLocus
ofSpleenLymphocytes
Additional ratsweretreated asdescribedabovewith0, 30, or
100 jg 1,6-dinitropyrene or Injected with 40 mg N-ethyl-N-
nitrosourea (ENU; 150 mg/ kg body weight). Thelatter group
served as apositivecontrol forthemutagenesis assays. Three, 9,
12, 15, and 21 weeks after surgery, two solvent-treated control
rats, two 1,6-dinitropyrene-treated rats, andoneENU-treated rat
were euthanized by exposure to carbon dioxide. Their spleens
were removed aseptically and lymphocytes were isolated and
pooledbygroup. ThenumberofT-lymphocytes withmutations
atthehprtlocus, asevidencedbygrowthofthelymphocytesinthe
presenceofthepurineanalog6-thioguanine, wasdeterminedby
thelimitingdilutionclonalassaydescribedinAidooetal. (10),
modified by using conditioned medium as a source of T-cell
growth factor (Aidoo et al., manuscript in preparation).
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FIGURE 1. Binding of 1,6-dinitropyrene to (A) lung nuclei and (B) spleen lym-
phocyte DNA. [4,5,9,10-3H]1,6-Dinitropyrene (30 or 100 lAg) was ad-
ministereddirectly intothe lungsofmale F344 rats. Atthetimes indicated,
the rats werekilled, lung nuclei andspleenlymphocytes wereprepared, DNA
was isolated, andtheextentofbinding wasquantifiedby UVand liquidscin-
tillation spectrometry. Thedata arepresented as means ± SD ofthree rats,
exceptforthe28-daypoint, whichonlyhad two rats. Asterisks indicatethat
DNA binding in the 100-jrg group was significantly greater than the 30-jAg
group: *p <0.1; **p<0.05; and ***p<0.01.
Results
Analysis of the Binding of 1,6-Dinitropyrene to
Lung andSpleen Lymphocyte DNA
The extentofbinding of 1,6-dinitropyrene to lung DNA after
lung implantation is shown inFigure IA. Ateach samplingpoint,
similarvalues werefoundwithbothdoses. Withthe 100-ltgtreat-
ment, maximumbindingoccurred7daysaftertreatment, while
withthe30-lsgdosethehighestlevelofbinding wasfound3days
afterdosing. Withbothtreatments, there was aslowdecreasein
thebindingsuchthatby28daysafterdosingbindinghaddecreased
to 25-50% ofthepeakvalues.
The magnitudeofadduct formation with spleen lymphocyte
DNA(Fig. IB) wasconsiderably lowerthanthatfoundwithlung
DNA (Fig. IA). As withlung DNA, thebinding tospleen lym-
phocyte DNAreached a maximum at7days aftertreatment for
the 100-itg dose and 3 days afterdosing forthe 30-pg group. In
contrast to lung DNA, there was a significant dose response in
A Lung
3-
2
1L -
Spleen Lymphocytes B
100pg
278MUTATIONINDUCT7ONIN VITROBY1, 6-DINITROPYRENE
C.)
0
E
-j
0
la
C)
0 HL
FIGURE 2. 32P-Postlabeling autoradiographs of(A) DNA standard modified
with N-(deoxyguanosin-8-yl)-1-amino-6-nitropyrene (dG-C8-ANP), (B) lung
nuclei from amaleF344rattreatedwith 100lpg[4,5,9,10_3HH1,6-dinitropyrene
andkilledafter7days,and(C)spleenlymphocyteDNAfromamaleF344 rat
that wastreated with 30pug[4,5,9,10_3H]1,6-dinitropyrene andsacrificed after
3 days.
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FIGURE 3. Mutation induction inspleenlymphocytesofmaleF344 ratstreated
with solvent or30 or 100 pg 1,6-dinitropyrene. Rats weregiven asingledose
ofthe compound indicated, killed after 3, 9, 12, 15, or 21 weeks, and the
numberof6-thioguanine-resistant (TGr) spleen T-lymphocytes was deter-
mined by means ofa limitingdilution clonal assay. At each time point, the
response inthe 100-pg group was significantly greaterthanthe 30-pg group
(p < 0.01).
thebinding to spleen lymphocyte DNA, withthebinding inthe
100-,ugdose groupbeing 1.5- to2.7-fold greaterthanthe 30-pg
group ateachtimepoint. Twenty-eightdaysaftertreatment, the
binding had decreased toabout 30% ofthe peak values.
AliquotsoflungandspleenlymphocyteDNA wereassayedby
32P-postlabeling (Fig. 2). Ineachinstance, asinglemajoradduct
wasdetectedthathadthe sameelutioncharacteristics asthead-
ductobtained from reactingN-hydroxy-l-amino-6-nitropyrene
with DNA. This adduct has been characterized as N-(deoxy-
guanosin-8-yl)-1-amino-6-nitropyrene (13).
Mutation Induction at the hprt Locus of Spleen
T-Lymphocytes
Mutations were assayed 3, 9, 12, 15, and 21 weeks after lung
implantationof0, 30, or 100jig of 1,6-dinitropyrene. As shown
in Figure 3, there was a significant increase in 6-thioguanine-
resistant (TGr) T-lymphocytes compared to the solvent-treated
controls, with the 100-lgdoseof 1,6-dinitropyrenetypically giv-
ing 2-fold more TGr T-lymphocytes than the 30-ag treatment.
The extentofinduction was relatively constantforthe first9-12
weeks and then increased with each subsequent sampling.
Thedirect-acting mutagen, ENU, injected IP at a concentra-
tion of 150 mg/kg body weight, induced between 189 and 387
TGrT-lymphocytes per 106cells ateach interval (p<0.001 com-
pared to control rats; data not shown).
Discussion
Iwagawa et al. (6) demonstrated that the administration of
1,6-dinitropyrene, acomponent ofdieselemissions, by thelung
implantation method of Stanton et al. (8) results in a dose-
dependent inductionoflung tumors in male F344 rats, with 30
and 100itgproducing40and 80% incidences, respectively. Us-
ing their protocol, we found that 1,6-dinitropyrene is metabo-
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lically activated by nitroreduction, presumably to N-hydroxy-
l-amino-6-nitropyrene, and that this latter compound either
directly or after subsequent activation reacts with DNA in the
target tissue to give N-(deoxyguanosin-8-yl)-1-amino-6-
nitropyrene. Although these doses of 1,6-dinitropyrene give
markedly different tumor incidences, a difference was not
observed inthebinding tolungDNAasafunctionofdose. This
may reflect the fact that the compound is localized within a
beeswaxpelletinasmallportionofthelung, andyettheadduct
analyses were conducted with DNA from the entire tissue. In
contrast to lung DNA, a dose-dependent formation of N-
(deoxyguanosin-8-yl)-1-amino-6-nitropyrene was found in
spleen lymphocyte DNA, with the 3.3-fold increase in dose
resulting inapproximately a2-foldincreaseinadductconcentra-
tion. The 2-fold difference in adductconcentration correlated
witha2-folddifferenceinthefrequencyofTGrT-lymphocytes
between 30 and 100 Ag 1,6-dinitropyrene. This suggests that
mutations arebeing inducedby 1,6-dinitropyrene treatmentand
that these mutations arethedirect resultofthe formation ofN-
(deoxyguanosin-8-yl)-l-amino-6-nitropyrene in spleen lym-
phocyte DNA. This interpretation needs to be confirmed by
molecular analyses of the DNA alterations in the putative
mutants.
InboththelungandspleenlymphocyteDNA, theconcentra-
tionofN-(deoxyguanosin-8-yl)-l-amino-6-nitropyrenedecreased
by 50-75% during a 1-monthperiodaftertreatment. Incontrast,
the frequency ofTGrT-lymphocytes remainedrelatively cons-
tant for approximately 9-12 weeks and then beganto increase.
Thus, lymphocyte mutations may be a longer-lived biomarker
than DNA adducts forassessingprevious exposurestogenotoxic
agents, such as nitro PAHs.
Lymphocyte mutation assays coupled with DNA adduct
measurements may alsobeimportanttools fordetermining the
riskassociatedwithexposuretomixtures. Dieselemissions, for
example, havebeenassociatedwiththeinductionoflungtumors
inboth rats(14) andhumans (2). AcomparisonoftheDNAad-
ductsobtainedfromexposing ratstodieselexhaustextracts (15)
and 1,6-dinitropyreneshouldallowadeterminationoftherelative
contribution of 1,6-dinitropyrene to thetumorigenic response.
Molecularanalysisofthemutationsinducedby 1,6dinitropyrene
in the rat model may indicate a fingerprint for mutation induc-
tion in terms ofthe types and location ofmutations in thehprt
gene. If 1,6-dinitropyrene contributes to the tumorigenic re-
sponse observed with diesel emissions, this mutational finger-
printshouldalsobefoundinanimalstreatedwithdieselexhaust
extracts. Mutation assays could then be conducted in humans
suspectedofbeingexposedtohighlevelsofdieselemissions. An
increase in TGr T-lymphocytes would provide a biological
assessmentoftheimpactofthisexposure, andmolecularanalysis
of the mutants would provide evidence that the biological
response was indeed dueto exposure to diesel emissions.
This manuscript waspresented asaposterattheConferenceonBiomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and RiskAssessment thatwas held in Kailua-Kona, Hawaii, 26
October-I November 1991.
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